The effect of drug resistance on the fitness of Mycobacterium tuberculosis

被引:141
|
作者
Cohen, T
Sommers, B
Murray, M
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
来源
LANCET INFECTIOUS DISEASES | 2003年 / 3卷 / 01期
关键词
D O I
10.1016/S1473-3099(03)00483-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Mycobacterium tuberculosis remains a leading infectious cause of morbidity and mortality. While antibiotic resistance is cited as a potential threat to efforts aimed at controlling the spread of this pathogen, it is not clear how drug resistance affects disease dynamics. The effect of mutational events that lead to anti biotic-resistant phenotypes may or may not have a predictable effect on the fitness of drug-resistant tuberculosis strains. Here, we review the literature on laboratory studies of the fitness of drug-resistant tuberculosis, we examine the evidence from cluster studies, and we consider the effect of drug resistance on disease dynamics in mathematical models. On the basis of these diverse lines of evidence, we conclude that the fitness estimates of drug-resistant M tuberculosis are quite heterogeneous and that this variation may preclude our ability to predict future trends of this pathogen.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 50 条
  • [21] Drug Resistance Mechanisms in Mycobacterium tuberculosis
    Palomino, Juan Carlos
    Martin, Anandi
    ANTIBIOTICS-BASEL, 2014, 3 (03): : 317 - 340
  • [22] Mechanisms of drug resistance in Mycobacterium tuberculosis
    Zhang, Y.
    Yew, W. W.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (11) : 1320 - 1330
  • [23] DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN CHANDIGARH
    MAHAJAN, RC
    AGARWAL, SC
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1968, 56 (08) : 1180 - &
  • [24] Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
    Lee, Jong-Hee
    Ammerman, Nicole C.
    Nolan, Scott
    Geiman, Deborah E.
    Lun, Shichun
    Guo, Haidan
    Bishai, William R.
    NATURE COMMUNICATIONS, 2012, 3
  • [25] Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
    Jong-Hee Lee
    Nicole C. Ammerman
    Scott Nolan
    Deborah E. Geiman
    Shichun Lun
    Haidan Guo
    William R. Bishai
    Nature Communications, 3
  • [26] Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis
    Rabaan, Ali A.
    Al Mutair, Abbas
    Albayat, Hawra
    Alotaibi, Jawaher
    Sulaiman, Tarek
    Aljeldah, Mohammed
    Al Shammari, Basim R.
    Alfaraj, Amal H.
    Al Fares, Mona A.
    Alwarthan, Sara
    Binjomah, Abdulwahab Z.
    Alzahrani, Mohammed S.
    Alhani, Hatem M.
    Almogbel, Mohammed S.
    Abuzaid, Abdulmonem A.
    Alqurainees, Ghaya
    Al Ibrahim, Fatimah
    Alhaddad, Ali H.
    Alfaresi, Mubarak
    Al-baghli, Nadira
    Alhumaid, Saad
    MOLECULES, 2022, 27 (20):
  • [27] Recent updates on drug resistance in Mycobacterium tuberculosis
    Singh, R.
    Dwivedi, S. P.
    Gaharwar, U. S.
    Meena, R.
    Rajamani, P.
    Prasad, T.
    JOURNAL OF APPLIED MICROBIOLOGY, 2020, 128 (06) : 1547 - 1567
  • [28] Drug resistance in Mycobacterium tuberculosis:: diagnostic methods
    Loïez-Durocher, C
    Vachée, A
    Lemaitre, N
    ANNALES DE BIOLOGIE CLINIQUE, 2000, 58 (03) : 291 - 297
  • [29] Molecular mechanisms of drug resistance in Mycobacterium tuberculosis
    Blanchard, JS
    ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 : 215 - 239
  • [30] Complex genetics of drug resistance in Mycobacterium tuberculosis
    Warner, Digby F.
    Mizrahi, Valerie
    NATURE GENETICS, 2013, 45 (10) : 1107 - 1108